We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $7.07M invested in Seelos Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,275% more call options, than puts

Call options by funds: $55K | Put options by funds: $4K

0% more funds holding

Funds holding: 2 → 2 (0)

31% less capital invested

Capital invested by funds: $10.2M → $7.07M (-$3.13M)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
–
Increased
–
Reduced
–
Closed
–
Calls
$55K
Puts
$4K
Net Calls
+$51K
Net Calls Change
-$6K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$32K
2
TSS
Two Sigma Securities
New York
-$19K
3
LPL Financial
LPL Financial
California
-$12K
4
BIM
BlackRock Investment Management
Delaware
-$6K
5
AIG
American International Group
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$5.78M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$604K – – –
HVC
3
Healthcare Value Capital
New Jersey
$176K – – –
California Public Employees Retirement System
4
California Public Employees Retirement System
California
$103K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$102K – – –
Franklin Resources
6
Franklin Resources
California
$44K – – –
Northern Trust
7
Northern Trust
Illinois
$35K – – –
Bank of New York Mellon
8
Bank of New York Mellon
New York
$29K – – –
VKH
9
Virtu KCG Holdings
New York
$27K – – –
CC
10
Callan Capital
California
$26K – – –
HighTower Advisors
11
HighTower Advisors
Illinois
$24K – – –
BIT
12
BlackRock Institutional Trust
California
$23K – – –
MFS
13
MSI Financial Services
Massachusetts
$14K – – –
Bank of America
14
Bank of America
North Carolina
$11K – – –
Wolverine Trading
15
Wolverine Trading
Illinois
$11K – – –
MBA
16
McQueen Ball & Associates
Pennsylvania
$10K – – –
GC
17
Guggenheim Capital
Illinois
$7K – – –
Creative Planning
18
Creative Planning
Kansas
$6K – – –
Group One Trading
19
Group One Trading
Illinois
$6K – – –
BA
20
BlackRock Advisors
Delaware
$5K – – –
State Street
21
State Street
Massachusetts
$5K – – –
BFA
22
BlackRock Fund Advisors
California
$4K – – –
FANJ
23
Financial Architects (New Jersey)
New Jersey
$4K – – –
Wells Fargo
24
Wells Fargo
California
$4K – – –
Morgan Stanley
25
Morgan Stanley
New York
$3K – – –
1
2

SEEL Hedge Fund Activity: Q2 2016 in Review

2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q2 2016, worth a combined $7.07M — down 31% from $10.2M a quarter earlier.

Fund positioning in SEEL was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Hudson Bay Capital Management, cutting an estimated $32K.

  • 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $7.07M of Seelos Therapeutics, Inc. Common Stock stock for Q2 2016, down 31% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q2 2016 and 0 closed out.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q2 2016 was Hudson Bay Capital Management, an estimated $32K sold.

Based on aggregated 13F filings for Q2 2016.